A Fresh Look at 1st Source (SRCE) Valuation After Recent Share Price Momentum

1st Source (SRCE) shares have seen some movement lately, drawing attention from investors curious about what is driving the change and how the recent performance compares to its broader track record in banking. Let's break down what the numbers reveal.

See our latest analysis for 1st Source.

1st Source’s share price is up 6.6% so far this year, with recent momentum fueled by steady revenue and net income growth. Even though the one-year total shareholder return remains slightly negative, its impressive five-year total return of 87% shows the stock has rewarded patient investors over the long run and could be regaining strength.

If this turnaround has sparked your curiosity, it could be a great opportunity to broaden your horizons and discover fast growing stocks with high insider ownership

With shares still trading about 18% below analyst price targets and notable growth in both revenue and net income, is 1st Source offering investors an attractive entry point, or has the market already recognized its potential for further gains?

Advertisement

Price-to-Earnings of 10.2x: Is it justified?

1st Source trades at a Price-to-Earnings (P/E) ratio of 10.2x, standing out as an apparent bargain compared to peer benchmarks. With the last close at $61.58 and this multiple well below sector averages, the market may be underestimating its earnings potential.

The P/E ratio shows how much investors are willing to pay for each dollar of earnings. For banks like 1st Source, it is a simple yet telling measure of market sentiment about future profit stability and growth. Right now, the stock looks attractively priced based on this metric.

Compared to the US Banks industry P/E average of 11.2x, 1st Source’s shares appear cheaper, possibly reflecting either an opportunity or a sign of caution. Its P/E is also well below the peer group average of 13.1x. While the fair P/E ratio estimate is 9.8x, 1st Source’s current valuation is only slightly above this calculated "fair" level, implying the market may be aligning expectations with fundamentals.

Explore the SWS fair ratio for 1st Source

Result: Price-to-Earnings of 10.2x (UNDERVALUED)

However, slower revenue growth and lingering negative one-year returns remain risks that could challenge the stock's current recovery momentum.

Find out about the key risks to this 1st Source narrative.

Another View: What Does Our DCF Model Say?

While the Price-to-Earnings ratio paints 1st Source as a potential bargain, our SWS DCF model offers a very different picture. This approach suggests the stock is trading a striking 53% below its fair value estimate, which hints at far more upside than the market implies. Could this fundamental value gap signal a real overlooked opportunity?

Look into how the SWS DCF model arrives at its fair value.

SRCE Discounted Cash Flow as at Nov 2025
SRCE Discounted Cash Flow as at Nov 2025

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out 1st Source for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 882 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own 1st Source Narrative

If you prefer to draw your own conclusions or want to dig deeper into the numbers yourself, you can shape a personal view in just a few minutes, and Do it your way.

A good starting point is our analysis highlighting 3 key rewards investors are optimistic about regarding 1st Source.

Looking for More Investment Ideas?

Give yourself an edge by tapping into fresh opportunities you may not have considered. These ideas could help you stay ahead as market trends evolve and new investment possibilities emerge every day.

  • Uncover stocks with rapid growth potential and strong financials by checking out these 3592 penny stocks with strong financials. This can help you spot opportunities before the next wave of attention lifts them higher.
  • Strengthen your income portfolio with higher yields and stable returns by exploring these 15 dividend stocks with yields > 3%. This resource is helpful for those seeking serious dividend power.
  • Capitalize on artificial intelligence trends by finding leaders in the space through these 27 AI penny stocks. Breakthrough innovations in this area are quickly reshaping industries.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:SRCE

1st Source

Operates as the bank holding company for 1st Source Bank that provides commercial and consumer banking services, trust and wealth advisory services, and insurance products to individual and business clients in the United States.

Flawless balance sheet with proven track record and pays a dividend.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1155.3% undervalued
50 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
BL
BlackGoat
IREN logo
BlackGoat on IREN ·

IREN's Bold Moves in Sustainable Bitcoin Mining & AI Data Centers

Fair Value:US$71.4849.2% undervalued
204 users have followed this narrative
6 users have commented on this narrative
32 users have liked this narrative
HE
HedgeY
ARM logo
HedgeY on Arm Holdings ·

The Architecture Layer of AI Computing - But Priced Like the Future Already Arrived?

Fair Value:US$43038.1% undervalued
9 users have followed this narrative
1 users have commented on this narrative
3 users have liked this narrative
HI
Hidden_Rock_Capital
FISV logo
Hidden_Rock_Capital on Fiserv ·

Temporary "perfect storm" leads to opportunity to buy financial services leader for less than 5x long-term earnings

Fair Value:US$119.9956.4% undervalued
13 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative

Updated Narratives

CL
Clive_Thompson
6831 logo
Clive_Thompson on Green Tea Group ·

One of China's Fastest-Growing Restaurant Chains Trades on Just 7x Earnings and an 8% Dividend

Fair Value:HK$8.728.9% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AZ
PRG logo
aziz_22khi on PRG Holdings Berhad ·

WHERE DID THE SIX MILLION SHARES GO? THE PRG OWNERSHIP TRAIL INVESTORS CANNOT IGNORE

Fair Value:RM 0.4477.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BR
Brunhilde_Wagner
CPRT logo
Brunhilde_Wagner on Copart ·

Compounder to Cash Generator in Real Time

Fair Value:US$2710.3% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.917.3% undervalued
86 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28029.8% undervalued
195 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.7% undervalued
72 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0
AN
CSMG3 logo
andre_k1tsg on Companhia de Saneamento de Minas Gerais ·

Gostei

0
|
0